A Clinical Trial to Evaluate the HeartWare® Ventricular Assist System

The purpose of this study is to determine the safety and effectiveness of the HeartWare Ventricular Assist System in patients with chronic Stage D/NYHA Class IIIB/IV left ventricular failure who have received and failed optimal medical therapy, and who are ineligible for cardiac transplantation.

Stanford Investigator(s)

CONTACT INFORMATION

Primary Contact:
Philip Oyer
(650) 725-3820